Cargando…

Randomized controlled study to evaluate the efficacy and safety of soticlestat as adjunctive therapy in adults with complex regional pain syndrome

OBJECTIVE: The objective was to investigate the efficacy and safety of soticlestat as adjunctive therapy in participants with complex regional pain syndrome (CRPS). DESIGN: A proof-of-concept phase 2a study, comprising a 15-week randomized, double-blind, placebo-controlled, parallel-group study (par...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ratcliffe, Stuart, Arkilo, Dimitrios, Asgharnejad, Mahnaz, Bhattacharya, Sudipta, Harden, R Norman
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Special Populations Section
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10321763/ https://www.ncbi.nlm.nih.gov/pubmed/36538782 http://dx.doi.org/10.1093/pm/pnac198

Ejemplares similares

A phase 2, randomized, double‐blind, placebo‐controlled study to evaluate the efficacy and safety of soticlestat as adjunctive therapy in pediatric patients with Dravet syndrome or Lennox–Gastaut syndrome (ELEKTRA)
por: Hahn, Cecil D., et al.
Publicado: (2022)

Research Recommendations Following the Discovery of Pain Sensitizing IgG Autoantibodies in Fibromyalgia Syndrome
por: Goebel, Andreas, et al.
Publicado: (2021)

Experiences of Patient-Led Chronic Pain Peer Support Groups After Pain Management Programs: A Qualitative Study
por: Farr, Michelle, et al.
Publicado: (2021)

ICD-11 Classification of Pediatric Chronic Pain Referrals in Ireland, with Secondary Analysis of Primary vs Secondary Pain Conditions
por: Matthews, Eveline, et al.
Publicado: (2021)

Low-dose naltrexone’s utility for non-cancer centralized pain conditions: a scoping review
por: Rupp, Adam, et al.
Publicado: (2023)

Understanding the Pain Management Landscape Within the US Bleeding Disorder Community: A Multi-Center Survey
por: Witkop, Michelle, et al.
Publicado: (2021)

Population pharmacokinetics, enzyme occupancy, and 24S‐hydroxycholesterol modeling of soticlestat, a novel cholesterol 24‐hydroxylase inhibitor, in healthy adults
por: Yin, Wei, et al.
Publicado: (2023)

Subtypes of complex regional pain syndrome—a systematic review of the literature
por: Knudsen, Lone, et al.
Publicado: (2023)

Prevalence and Impact of Dysmenorrhea Among University Students in Ireland
por: Durand, Hannah, et al.
Publicado: (2021)

The Effect of the Model’s Social Status on Placebo Analgesia Induced by Social Observational Learning
por: Bieniek, Helena, et al.
Publicado: (2021)

Pharmacokinetics, Safety, and Tolerability of Oral Semaglutide in Subjects With Hepatic Impairment
por: Bækdal, Tine A., et al.
Publicado: (2018)

The Pharmacology, Efficacy, and Safety of Rivaroxaban in Renally Impaired Patient Populations
por: Ashton, Veronica, et al.
Publicado: (2021)

Influence of Renal Function on Pharmacokinetics, Pharmacodynamics, and Safety of a Single Dose of Romosozumab
por: Hsu, Cheng‐Pang, et al.
Publicado: (2022)

Evaluation of the Pharmacokinetics and Safety of a Single Dose of Acalabrutinib in Subjects With Hepatic Impairment
por: Xu, Yan, et al.
Publicado: (2022)

Pharmacokinetics, Pharmacodynamics, and Safety of Peginterferon Beta-Ia in Subjects with Normal or Impaired Renal Function
por: Hu, Xiao, et al.
Publicado: (2015)

Cardiovascular safety profile of taxanes and vinca alkaloids: 30 years FDA registry experience
por: Batra, Akshee, et al.
Publicado: (2021)

Pharmacokinetics, pharmacodynamics and safety assessment of multiple doses of soticlestat in healthy volunteers
por: Wang, Shining, et al.
Publicado: (2022)

Pharmacokinetics and Safety of a Single Oral Dose of Mirogabalin in Japanese Subjects With Varying Degrees of Renal Impairment
por: Kato, Manabu, et al.
Publicado: (2017)

Cefiderocol, a Siderophore Cephalosporin for Gram‐Negative Bacterial Infections: Pharmacokinetics and Safety in Subjects With Renal Impairment
por: Katsube, Takayuki, et al.
Publicado: (2016)

Single‐Center Evaluation of the Pharmacokinetics and Safety of the Angiotensin II Receptor Antagonist Azilsartan Medoxomil in Mild to Moderate Hepatic Impairment
por: Dudkowski, Caroline, et al.
Publicado: (2017)

Single‐Dose Pharmacokinetics and Safety of Solriamfetol in Participants With Normal or Impaired Renal Function and With End‐Stage Renal Disease Requiring Hemodialysis
por: Zomorodi, Katie, et al.
Publicado: (2019)

Maribavir Pharmacokinetics and Safety in Participants With Moderate Hepatic Impairment: A Phase 1, Open‐Label, Single‐Dose, Parallel Group Study
por: Song, Ivy, et al.
Publicado: (2022)

Complex Regional Pain Syndrome: Practical Diagnostic and Treatment Guidelines, 5th Edition
por: Harden, R Norman, et al.
Publicado: (2022)

Pregnancy course and outcomes in women with arrhythmogenic right ventricular cardiomyopathy
por: Hodes, Anke R, et al.
Publicado: (2016)

Safety, tolerability, pharmacokinetics, pharmacodynamics, bioavailability and food effect of single doses of soticlestat in healthy subjects
por: Wang, Shining, et al.
Publicado: (2021)

Impact of chronic obstructive pulmonary disease on morbidity and mortality after myocardial infarction
por: Andell, Pontus, et al.
Publicado: (2014)

Access to Medicaid and Medicare by the low-income disabled
por: Ellwood, Marilyn Rymer, et al.
Publicado: (1990)

Medicaid-financed residential care for persons with mental retardation
por: Lakin, K. Charlie, et al.
Publicado: (1990)

Medicaid mysteries: Transitional benefits, Medicaid coverage, and welfare exits
por: Ellwood, David T., et al.
Publicado: (1990)

Cardiac troponin I but not cardiac troponin T adheres to polysulfone dialyser membranes in an in vitro haemodialysis model: explanation for lower serum cTnI concentrations following dialysis
por: Gaze, David C, et al.
Publicado: (2014)

Heart rate variability analysis during head-up tilt test predicts nitroglycerine-induced syncope
por: Efremov, Kristian, et al.
Publicado: (2014)

Pharmacokinetics of the Dual Melatonin Receptor Agonist Tasimelteon in Subjects With Hepatic or Renal Impairment
por: Torres, Rosarelis, et al.
Publicado: (2015)

Subtle increases in heart size persist into adulthood in growth restricted babies: the Cardiovascular Risk in Young Finns Study
por: Arnott, Clare, et al.
Publicado: (2015)

Subclinical cardiopulmonary dysfunction in stage 3 chronic kidney disease
por: Nelson, Alexander, et al.
Publicado: (2016)

Maternal ethnicity and its impact on the haemodynamic and blood pressure response to labetalol for the treatment of antenatal hypertension
por: Stott, D, et al.
Publicado: (2016)

Effects of paediatric HIV infection on electrical conduction of the heart
por: Idris, Nikmah S, et al.
Publicado: (2016)

Pharmacokinetics of renally excreted drug dexpramipexole in subjects with impaired renal function
por: He, Ping, et al.
Publicado: (2014)

Cardiovascular disease in HIV patients: from bench to bedside and backwards
por: Cerrato, Enrico, et al.
Publicado: (2015)

Closing the mortality gap after a myocardial infarction in people with and without chronic obstructive pulmonary disease
por: Rothnie, Kieran J, et al.
Publicado: (2015)

Sympathetic autonomic dysfunction and impaired cardiovascular performance in higher risk surgical patients: implications for perioperative sympatholysis
por: Whittle, John, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_bat4fnl0a64euuldlo3ik4e3hr